Two new managers for Sicomed

Sicomed Bucharest, the largest Romanian drugmaker, brought more foreign managers to join its management team, after the majority shareholders of the company (two investment funds) appointed Dutch-born Klaas Postema CEO in the summer of 2002. Therefore the CFO position has been filled by Arend Gerrit Bristra since last week, while the vice-president of business development position went to Edward Thomas Kania. Bristra (52) is a Dutch citizen, has been working in the pharmaceutical industry for 17 years and his last position was that of VP of finance and accounting with the European division of Japanese Yamanouchi pharmaceutical group. Kania (55) is a Swiss citizen, and was Ivax Group’s general manager for Central and Eastern Europe (former Soviet countries inclusive) from 1998 through 2003. While at Sicomed he will run the Marketing and Sales, Research and Development and Relations with Authorities departments. “Sicomed has been through a time of important changes in terms of internal organisation. The goals its development strategy targets for the next few years are very bold, but bringing the two new members on board who have an extensive expertise in the pharmaceutical industry, will give investors, business partners and employees more security about Sicomed’s future,” Klaas Postema, Sicomed’s CEO said. ZF